Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 590, pseudogene (RNU6-590P) is classified as a non-coding RNA pseudogene in the human genome[4][6]. It is derived from the U6 small nuclear RNA (snRNA) gene family, which encodes essential components of the spliceosome complex involved in pre-mRNA splicing[1][3][5]. However, as a pseudogene, RNU6-590P is recognized as a non-functional, transcriptionally inactive copy or relic of a once-functional U6 snRNA gene; it does not encode a functional RNA product and does not directly participate in RNA splicing or other biological functions[4][5][6]. Pseudogenes like RNU6-590P may result from gene duplication or retrotransposition events and typically exhibit sequence homology to genuine genes but lack activity due to mutations, deletions, or insertions[5]. There is no evidence for a functional or regulatory role, nor is there chemical or pharmacological interest in this specific pseudogene[4][6].
None (No therapeutic mechanism of action; not a target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 590, pseudogene (RNU6-590P).